2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

61 - 

Bioglass 45S5, a relevant alternative to autogenous harvesting for secondary alveolar bone grafts in clefts? Retrospective study of one hundred surgeries

Emmanuelle F. Verdier, Apolline L. Saloux, Olivier M. Azzis, Ronan Lebullenger, Tiphaine A. Davit-Béal et al.

Journal of Cranio-Maxillofacial Surgery, 2023, Journal of Cranio-Maxillofacial Surgery,

DOI : https://doi.org/10.1016/j.jcms.2023.12.005

Pubmed : 38129189

 

62 - 

Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicenter randomised controlled trial

Muriel Fartoukh, Saad Nseir, Bruno Mégarbane, Yves Cohen, Antoine Lafarge et al.

Clinical Microbiology and Infection, 2023, 29 (6), pp.734-743.

DOI : https://doi.org/10.1016/j.cmi.2023.01.009

Pubmed : 36681325

 

63 - 

Antimicrobial Exposure: Do Not Forget the Patient's Condition Beneath the Extracorporeal Membrane Oxygenation Support!

Pierre Fillatre, Florian Lemaitre, Nicolas Nesseler, François Legay, Nicolas Massart et al.

American Journal of Respiratory and Critical Care Medicine, 2023, 207 (7), pp.950-951.

DOI : https://doi.org/10.1164/rccm.202210-1945LE

Pubmed : 36473252

 

64 - 

Characteristics, management, and outcomes of patients with infectious encephalitis requiring intensive care: A prospective multicentre observational study

Pierre Fillâtre, Alexandra Mailles, Jean-Paul Stahl, Pierre Tattevin

Journal of Critical Care, 2023, 77, pp.154300.

DOI : https://doi.org/10.1016/j.jcrc.2023.154300

Pubmed : 37207520

 

65 - 

Perspectives of patient educators about their participation in an interprofessional program for healthcare students and postgraduate medical students

Laure Fiquet, Marie Dupard, Hélène Fortier, M. Pancher, Françoise Annezo et al.

Journal of Interprofessional Care, 2023, 37 (3), pp.464-472.

DOI : https://doi.org/10.1080/13561820.2022.2099817

Pubmed : 36153743

 

66 - 

Infections sur prothèse vasculaire

Lucas Fischer, Matthieu Revest

Médecine et Maladies Infectieuses Formation, 2023, 2 (2), pp.69-77.

DOI : https://doi.org/10.1016/j.mmifmc.2023.03.379

 

67 - 

Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study

Claire Fougerou-Leurent, Christelle Delmas, Juliette Saillard, Marina Dumousseaux, Assia Ferrane et al.

Contemporary Clinical Trials, 2023, 131, pp.107267.

DOI : https://doi.org/10.1016/j.cct.2023.107267

Pubmed : 37302469

 

68 - 

Assessment of DOAC in GEriatrics (ADAGE study): rivaroxaban/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients

Geoffrey Foulon-Pinto, Carmelo Lafuente, Georges Jourdi, Julien Le Guen, Fatoumata Tall et al.

Thrombosis and Haemostasis, 2023, 123 (04), pp.402-414.

DOI : https://doi.org/10.1055/a-1981-1763

Pubmed : 36395818

 

69 - 

Clinical value of serial quantitative analysis of cytomegalovirus DNA in blood and saliva over the first 24 months of life congenital infection: the French Cymepedia Cohort

Jacques Fourgeaud, Jean-François Magny, Sophie Couderc, Patricia Garcia, Anne-Marie Maillotte et al.

The Journal of Pediatrics, 2023, 253, pp.197-204.e5.

DOI : https://doi.org/10.1016/j.jpeds.2022.09.040

Pubmed : 36181870

 

70 - 

DOP89 Impact of biologics on the risk of early postoperative complications in Crohn's disease: a French nationwide study

Mathurin Fumery, S Nancey, M Nachury, M Allez, C Rouillon et al.

Journal of Crohn's and Colitis, 2023, 17 (Supplement 1), pp.i166-i167.

DOI : https://doi.org/10.1093/ecco-jcc/jjac190.0129